Cargando…
Hearing function after betahistine therapy in patients with Ménière's disease()
INTRODUCTION: Preventing or reversing hearing loss is challenging in Ménière's disease. Betahistine, as a histamine agonist, has been tried in controlling vertigo in patients with Ménière's disease, but its effectiveness on hearing problems is not known. OBJECTIVE: To examine the effect of...
Autores principales: | Seyed Tootoonchi, Seyed Javad, Ghiasi, Samad, Shadara, Parvaneh, Samani, Simin Mirakhor, Fouladi, Daniel Fadaei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444678/ https://www.ncbi.nlm.nih.gov/pubmed/26810620 http://dx.doi.org/10.1016/j.bjorl.2015.08.021 |
Ejemplares similares
-
Betahistine in the treatment of Ménière’s disease
por: Lacour, Michel, et al.
Publicado: (2007) -
Association of cinnarizine and betahistine in prophylactic therapy for Ménière's disease with and without migraine
por: Teggi, R., et al.
Publicado: (2014) -
Good Clinical Approach: Delphi Consensus for the Use of Betahistine in Menière's Disease
por: Casani, Augusto Pietro, et al.
Publicado: (2018) -
Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière's disease: a 10-year experience
por: Monzani, D., et al.
Publicado: (2012) -
Report from a Consensus Conference on the treatment of Ménière’s disease with betahistine: rationale, methodology and results
por: CASANI, A.P., et al.
Publicado: (2018)